• Saracatinib: From Src Biology to Translation

  2026-09-02

  Saracatinib (AZD0530) offers translational researchers a mechanism-led way to interrogate Src family kinase and Abl signaling across cancer models, while the Reelin–SFK literature illustrates why pathway context matters beyond oncology. This article connects biochemical potency with assay design, model selection, and responsible cross-domain interpretation.

• Phebestin Reveals a New Antiplasmodial Strategy

  2026-09-01

  The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial candidate active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its combination of parasite-stage activity, persistent morphological effects, computational target analysis, and mouse efficacy supports aminopeptidases as a useful therapeutic vulnerability while leaving target validation and translational pharmacology unresolved.

• TMRE mitochondrial membrane potential assay kit Guide

  2026-09-01

  Learn how to use a TMRE mitochondrial membrane potential assay kit to connect mitochondrial depolarization with apoptosis, sodium-driven energy failure, and broader mitochondrial physiology. This workflow emphasizes CCCP validation, scalable plate design, orthogonal controls, and troubleshooting for cell, tissue, and purified mitochondria samples.

• Nadolol (SQ-11725) in Cell Assay Workflows

  2026-08-31

  A scenario-driven guide to using Nadolol (SQ-11725), SKU BA5097, in cell viability, proliferation, and cytotoxicity workflows. It covers mechanism-aware controls, solution handling, protocol parameters, transporter-related interpretation, and evidence-based product selection.

• Anisomycin Workflows for JNK and Apoptosis

  2026-08-31

  Build reproducible Anisomycin experiments around controlled JNK activation, orthogonal apoptosis readouts, and disciplined vehicle and stability controls. The workflow also explains how a 2025 social-memory study informs neuroscience assay design without overstating Anisomycin as a validated memory reagent.

• CCK-8 for Stem Cell Differentiation Readouts

  2026-08-30

  Learn how CCK8 can quantify viable-cell changes during human embryonic stem cell differentiation without confusing metabolic activity with absolute cell number. This guide connects WST-8 assay design with new findings on mTORC2, adhesion, and WNT signaling.

• Resazurin Cell Viability Assay Kit Guide

  2026-08-29

  Learn how Resazurin Cell Viability Assay Kit SKU K2234 can address sensitivity, throughput, and assay-interference challenges in cell viability and proliferation studies. This scenario-based guide connects practical workflow decisions with evidence from recent osteobiology research and documented product specifications.

• PP 1: Src Family Tyrosine Kinase Inhibitor Guide

  2026-08-28

  PP 1 is a practical, nanomolar research tool for separating Lck, Fyn, and Lyn-dependent signaling from downstream kinase effects. This workflow-focused guide covers dose selection, T cell activation modulation, RET oncogene inhibition, controls, and troubleshooting for reproducible cancer and immunology assays.

• Hydrocortisone and the Next Frontier of Splicing Biology

  2026-08-28

  Hydrocortisone is more than a routine medium supplement. This thought-leadership guide explains how glucocorticoid context can sharpen studies of EMT, metastasis, inflammation, and stress biology while preventing overinterpretation of splicing results.

• GlycoRNA–RBP Surface Domains and TAT Peptide Entry

  2026-08-27

  The reference preprint presents evidence that cell-surface RNA-binding proteins and glycoRNAs organize into RNA-sensitive nanoclusters that support uptake of the cell-penetrating peptide TAT. Its findings broaden the molecular definition of the cell surface and suggest that extracellular RNA–protein domains should be considered when interpreting peptide entry and surface-interaction assays.

• Doxorubicin Hydrochloride: Assay Design Guide

  2026-08-27

  Doxorubicin hydrochloride is more than a cytotoxic control: it is a versatile probe for linking DNA damage, metabolic stress, apoptosis, and cardiac injury. This assay-centered guide translates recent ferroptosis and Nrf2/HO-1 findings into practical cancer and cardiotoxicity model decisions.

• Computational Hapten Design for Dual Toxin Detection

  2026-08-26

  The reference study combines molecular similarity analysis, quantum chemical calculations, and antibody engineering to create a dual-target fluorescent immunochromatographic assay for amatoxins and phallotoxins in mushrooms. Its results show that rational hapten selection can improve cross-reactive toxin recognition while enabling sensitive, field-oriented screening of two clinically important toxin families.

• CCK-8: From Metabolic Signal to Translational Insight

  2026-08-26

  Cell Counting Kit-8 (CCK-8) is more than a convenient viability reagent: interpreted through WST-8 chemistry, it can help translational researchers connect cell-state changes with therapeutic mechanism. This article examines how CCK-8 can support exosome-based cartilage repair research while clarifying its limits and the need for orthogonal validation.

• Merimepodib (VX-497): The IMPDH Translation Playbook

  2026-08-25

  Merimepodib (VX-497) offers translational researchers a mechanistically defined way to interrogate IMPDH-dependent guanine nucleotide biosynthesis across antiviral, immunology, and cancer models. Recent PEDV research strengthens the case for treating IMPDH inhibition as a testable host-dependency strategy rather than simply a broad metabolic intervention.

• Heparin Sodium as a Mechanistic Assay Tool

  2026-08-25

  Heparin sodium is more than a glycosaminoglycan anticoagulant: it can serve as a controlled variable in coagulation, nanovesicle uptake, and cell-state studies. This article connects antithrombin-dependent anticoagulation with HSPG-mediated cellular uptake while defining practical controls and experimental limitations.

8442 records 1/563 page Next 12345 下5页 Last page